HIT Consultant January 18, 2024
Jasmine Pennic

What You Should Know:

Fitbit, the leader in wearable technology, and Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services, announced the launch of the Wearables for Metabolic Health (WEAR-ME) pilot study.

– This pilot study will explore the potential of wearable devices to revolutionize how we assess and manage metabolic health, a key factor in preventing chronic diseases like diabetes and heart disease.

Beyond Steps: Wearables for Deeper Insights

While wearables have become our ubiquitous companions, tracking steps and sleep, their true potential lies in their ability to shed light on our internal health. WEAR-ME aims to bridge the gap between activity data and actionable health insights. By pairing Fitbit’s rich collection of biometric data with the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Provider, Survey / Study, Technology, Trends, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article